Trial Profile
Clinical Trials Insight: 700032665
Status:
Planning
Phase of Trial:
Clinical Phase Unknown
Latest Information Update: 17 Apr 2008
Price :
$35
*
At a glance
- Drugs Grass pollen allergy immunotherapy (Primary)
- Indications Grass pollen hypersensitivity
- Focus Therapeutic Use
- Sponsors Stallergenes SA
- 17 Apr 2008 New trial record.